Home » Chemicals » Molecular Glues Market

Molecular Glues Market By Type (Proteolysis Targeting Chimeras (PROTACs), Specific & Non-genetic IAP-dependent Protein Erasers, Target Oriented Protein Degrader Optimizer, Lysosomal Targeting Chimeras, Others); By Application (Therapeutics: Cancer Treatment, Neurodegenerative Diseases, Infectious Diseases; Diagnostic Tools: Biomarker Detection, Protein Interaction Mapping; Drug Development, Biological Research, Others); By Process (Proteolysis Targeting Chimeras (PROTACs), Specific & Non-genetic IAP-dependent Protein Erasers, Target Oriented Protein Degrader Optimizer, Lysosomal Targeting Chimeras, Others); By End User (Pharmaceutical Companies, Biotechnology Companies, Diagnostic Laboratories, Academic and Research Institutions, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Molecular Glues Market Size 2023	USD 58,021.34 Million
Molecular Glues Market, CAGR	5.70%
Molecular Glues Market Size 2032	USD 95,557.03 Million

Market Overview

The Molecular Glues Market is projected to grow from USD 58,021.34 million in 2023 to USD 95,557.03 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.70%.

The Global Molecular Glues Market is driven by the increasing demand for innovative therapeutic approaches in treating complex diseases, particularly in oncology and neurodegenerative disorders. The growing focus on targeted protein degradation and advancements in drug discovery technologies are accelerating the adoption of molecular glues. Additionally, ongoing research and development efforts, coupled with strategic collaborations between pharmaceutical companies and research institutions, are propelling market growth. The rising awareness of the potential of molecular glues in developing next-generation therapeutics further underscores their expanding role in the global pharmaceutical landscape.

The Global Molecular Glues Market is witnessing significant growth across key regions, with North America leading due to its advanced biotechnology infrastructure and strong presence of pharmaceutical giants like Pfizer Inc. and Bristol-Myers Squibb. Europe follows closely, driven by robust R&D activities and the presence of innovative companies such as Proxygen GmbH and Evotec SE. The Asia-Pacific region is rapidly emerging as a key player, fueled by increasing investments in drug discovery and development. Key players in the market are focusing on expanding their global reach through strategic partnerships and cutting-edge research to capitalize on this growing demand.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Secondary Market Drivers: Venture Capital and Government Support

The high potential of molecular glues has attracted significant venture capital investments, which are crucial for supporting the early-stage research and development necessary to bring these novel therapies to market. Increased funding from venture capitalists underscores the confidence in the commercial viability and transformative potential of molecular glues. For instance, companies working on targeted protein degraders (TPDs) have raised more than $2 billion in venture financing. Additionally, government grants and incentives have provided further support, accelerating the pace of innovation and reducing the financial risks associated with pioneering new drug development approaches. These secondary drivers are essential in sustaining the momentum of the molecular glues market as it continues to evolve and expand.

Success of Early-Stage Drug Candidates and Potential for Personalized Medicine

The successful development and clinical validation of early-stage molecular glue-based drugs have generated significant interest and investment in this market. These successes have demonstrated the practical viability of molecular glues as a therapeutic strategy, encouraging further exploration and expansion in this area. For example, the International Consortium for Personalised Medicine (ICPerMed) envisions that personalized medicine (PM) will lead to the next generation of healthcare by 2030. Moreover, molecular glues hold great promise for personalized medicine, as they enable the creation of targeted therapies tailored to individual patients’ genetic profiles. This potential for highly personalized treatment approaches is driving demand and fostering innovation in the molecular glues market, aligning with the broader trend toward precision medicine.

Unmet Medical Needs and Advancements in Drug Discovery

The Global Molecular Glues Market is significantly driven by the growing need for innovative therapeutic strategies to address complex diseases that traditional drug development approaches have struggled to treat effectively. Molecular glues offer a groundbreaking solution by enabling the targeting of previously undruggable proteins, which is crucial for conditions like cancer and neurodegenerative disorders. Additionally, advancements in drug discovery have played a pivotal role in this market’s growth. The increasing understanding of protein-protein interactions, combined with the development of sophisticated computational tools, has made it possible to identify novel molecular glue targets, paving the way for more precise and effective treatments.

Collaboration and Partnerships Driving Innovation

The complex and interdisciplinary nature of molecular glue development has led to numerous collaborations between pharmaceutical companies, biotechnology firms, and academic institutions. These partnerships are essential for accelerating drug discovery and development, as they combine expertise, resources, and technologies from various fields. Collaborative efforts have been instrumental in advancing the understanding and application of molecular glues, leading to more robust and diverse pipelines of drug candidates. This collaborative environment is a key driver of growth and innovation in the molecular glues market.

Market Trends

Integration of AI and Public-Private Partnerships Enhancing Innovation

The integration of artificial intelligence (AI) and machine learning (ML) is revolutionizing the molecular glues market by enhancing target identification, drug design, and optimization processes. AI-driven algorithms are being used to predict the interactions between molecular glues and their target proteins, significantly improving the accuracy and efficiency of drug development. This technological integration is enabling the discovery of novel targets and the design of more effective and specific molecular glue compounds. A government report indicates that the number of public-private partnerships in the molecular glues field has doubled in the past two years, with over $500 million in joint funding allocated to these collaborations. Concurrently, public-private partnerships are playing a crucial role in fostering innovation and accelerating drug development. Collaborations between pharmaceutical companies, academic institutions, and government agencies are pooling resources and expertise, driving forward the research and development of molecular glues. These partnerships are instrumental in overcoming the challenges associated with the development of novel therapeutics, ensuring that promising drug candidates reach the market more swiftly.

Expanding Therapeutic Applications and Platform Technologies

The Global Molecular Glues Market is witnessing a significant expansion in therapeutic applications beyond its initial focus on oncology. Molecular glues are now being explored for their potential in treating a broader range of conditions, including immunology, neurodegenerative diseases, and fibrosis. This expansion is driven by the growing recognition of molecular glues’ ability to target previously undruggable proteins, offering new avenues for therapeutic intervention in these complex diseases. Additionally, companies are developing platform technologies to streamline and accelerate the discovery and development of molecular glues. These platforms are designed to increase the efficiency of drug development by enabling rapid identification and optimization of molecular glue candidates, thereby shortening the time to market for new therapies.

Market Challenges Analysis

High Development Costs and Technical Challenges in Molecular Glue Development

The development of molecular glues presents significant financial and technical challenges, which are critical hurdles for the market. Developing these compounds is inherently complex and requires substantial investment in research and development. For instance, a survey by the National Health Commission found that the average cost of developing a molecular glue drug is 35% higher than traditional small molecule drugs. The intricate process of designing molecular glues involves identifying suitable target proteins, which is complicated by the complexity of protein-protein interactions. These interactions are often highly specific and difficult to modulate, making the design and optimization of effective molecular glues a formidable task. Government data shows that only 1 in 10,000 molecular glue candidates successfully progresses from initial discovery to clinical trials. The high costs associated with these research efforts are compounded by the need for advanced technologies and specialized expertise, making it difficult for smaller companies to compete and slowing the pace of innovation in the field.

Safety, Intellectual Property, and Regulatory Hurdles

Ensuring the safety and efficacy of molecular glues is another major challenge, as these compounds can potentially interfere with multiple protein-protein interactions, leading to off-target effects and toxicity. Safety and tolerability must be rigorously evaluated, adding to the complexity and duration of the drug development process. Moreover, protecting intellectual property (IP) in this rapidly evolving field is becoming increasingly challenging. The fast pace of innovation can lead to potential patent disputes, and the complex nature of molecular glue technology makes it difficult to secure comprehensive IP protection. Regulatory hurdles further complicate the landscape, as navigating the approval process for novel therapeutics is often time-consuming and expensive. Regulatory bodies require extensive clinical data to ensure the safety and efficacy of new drugs, but the limited clinical experience with molecular glues means that obtaining this data can be challenging, delaying market entry.

Market Segmentation Analysis:

By Type:

The Global Molecular Glues Market is segmented into various types, including Proteolysis Targeting Chimeras (PROTACs), Specific & Non-genetic IAP-dependent Protein Erasers, Target Oriented Protein Degrader Optimizer, Lysosomal Targeting Chimeras, and Others. Among these, PROTACs have garnered significant attention due to their ability to target previously undruggable proteins, offering a novel approach to therapeutic development. Specific & Non-genetic IAP-dependent Protein Erasers and Lysosomal Targeting Chimeras are also gaining traction for their innovative mechanisms in protein degradation. The market’s diversity in molecular glue types reflects the growing interest and investment in this cutting-edge technology, aimed at addressing complex biological challenges.

By Application:

Molecular glues have broad applications across various domains. In therapeutics, they are particularly promising in cancer treatment, neurodegenerative diseases, and infectious diseases, where they offer targeted and effective solutions. The diagnostic tools segment benefits from molecular glues in biomarker detection and protein interaction mapping, enhancing the precision of diagnostic processes. Additionally, molecular glues play a crucial role in drug development and biological research, driving innovation and efficiency in these fields. The diverse applications of molecular glues underscore their potential to revolutionize multiple aspects of medical and scientific research.

Segments:

Based on Type:

Proteolysis Targeting Chimeras (PROTACs)
Specific & Non-genetic IAP-dependent Protein Erasers
Target Oriented Protein Degrader Optimizer
Lysosomal Targeting Chimeras
Others

Based on Application:

Therapeutics
Cancer Treatment
Neurodegenerative Diseases
Infectious Diseases
Diagnostic Tools
Biomarker Detection
Protein Interaction Mapping
Drug Development
Biological Research
Others

Based on Process:

Proteolysis Targeting Chimeras (PROTACs)
Specific & Non-genetic IAP-dependent Protein Erasers
Target Oriented Protein Degrader Optimizer
Lysosomal Targeting Chimeras
Others

Based on End User:

Pharmaceutical Companies
Biotechnology Companies
Diagnostic Laboratories
Academic and Research Institutions
Others

Based on the Geography:

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

Regional Analysis

North America

North America holds the largest market share, accounting for approximately 40% of the global market. This dominance is driven by the presence of leading pharmaceutical and biotechnology companies, a strong focus on research and development, and extensive funding from both government and private sectors. The United States, in particular, is a significant contributor to this region’s market share, supported by advanced healthcare infrastructure and a high demand for innovative therapeutic solutions. The region’s early adoption of cutting-edge technologies and its strong intellectual property framework further solidify its leading position in the molecular glues market.

Europe

Europe follows closely, capturing around 30% of the market share. The region’s growth is propelled by robust R&D activities, particularly in countries like Germany, the UK, and Switzerland, which are known for their strong pharmaceutical industries and collaborative research environments. For instance, the rising demand from a variety of end-use industries, including the skincare and health care sectors, is driving the growth of the molecular glues market in Europe. The European Union’s supportive regulatory framework and incentives for drug development also play a crucial role in fostering innovation within the molecular glues market.

Key Player Analysis

Proxygen GmbH
Tocris Bioscience
Pfizer Inc.
Takeda Pharmaceuticals
LifeSensors Inc.
Evotec SE
Eli Lilly and Company
Bristol-Myers Squibb Company
C4 Therapeutics, Inc.
Seed Therapeutics, Inc.
Ranok Therapeutics Co. Ltd.
Venquis Therapeutics
Monte Rosa Therapeutics Inc.
Sygnature Discovery
Domainex

Competitive Analysis

The Global Molecular Glues Market is highly competitive, with key players such as Pfizer Inc., Bristol-Myers Squibb, Eli Lilly and Company, and Takeda Pharmaceuticals leading the market. These companies maintain a competitive edge through extensive research and development efforts, robust product portfolios, and strategic collaborations. Pfizer and Bristol-Myers Squibb are at the forefront of developing novel molecular glue therapies, leveraging their deep expertise in oncology and immunology. Eli Lilly and Takeda are also making significant strides by focusing on personalized medicine and targeted therapies. Emerging players like Proxygen GmbH and C4 Therapeutics are gaining traction by innovating in the niche areas of proteolysis-targeting chimeras (PROTACs) and specific protein degradation technologies. The competition is intensified by the continuous advancements in drug discovery platforms and the integration of artificial intelligence to accelerate the development of next-generation molecular glues, making this market dynamic and fast-evolving.

Recent Developments

In May 2024, Evotec reported financial results for the first quarter ended March 31, 2024, as well as recent business highlights. The company is on track to meet its goal of launching 20 new medicines over the 10-year period from 2014 to 2023.
In October 2023, Seed Therapeutics announced that it had successfully discovered ST-00937, a new chemical entity (NCE) molecular glue that has already achieved IND Candidate status and will be advanced for the treatment of cancers in SEED’s first IND filing, as early as 2024.
In October 2022, Tocris Bioscience announced a new standard in highly sensitive RNA imaging. They brought together gold-standard spatial biology RNAscope™ ISH technology with exceptionally bright TSA Vivid™ Fluorophores to provide industry-leading, highly-sensitive RNA detection for any gene, species, or tissue.
In April 2023, Proxygen signed a licensing agreement with Merck & Co. worth more than $2.55 billion.

Market Concentration & Characteristics

The Global Molecular Glues Market is characterized by moderate to high market concentration, with a few leading pharmaceutical and biotechnology companies holding significant market shares. These key players, such as Pfizer Inc., Bristol-Myers Squibb, and Takeda Pharmaceuticals, drive market growth through extensive research and development efforts, strong intellectual property portfolios, and strategic collaborations. The market’s competitive landscape is shaped by the complex and innovative nature of molecular glue development, which requires significant investments in technology and expertise. The high barriers to entry, including the need for advanced scientific capabilities and regulatory approvals, limit the number of new entrants. Additionally, the market is defined by rapid advancements in drug discovery technologies and a focus on developing targeted therapies for previously undruggable proteins, which further intensifies competition among the existing players. Overall, the market’s concentration reflects the critical importance of innovation, strategic partnerships, and technological expertise in maintaining a competitive edge.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Coverage

The research report offers an in-depth analysis based on Type, Application, Process, End User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for molecular glues will continue to grow as they offer novel solutions for targeting previously undruggable proteins.
Advancements in drug discovery technologies will accelerate the identification and development of new molecular glue candidates.
The application of molecular glues is expected to expand beyond oncology into areas like neurodegenerative diseases and immunology.
Increased collaboration between pharmaceutical companies and academic institutions will drive innovation in the molecular glues market.
The integration of artificial intelligence and machine learning will enhance the efficiency and precision of molecular glue development.
Venture capital investments in molecular glue-focused startups are likely to rise, fueling further market growth.
Regulatory frameworks will evolve to accommodate the unique challenges posed by molecular glue therapies, streamlining approval processes.
The market will see increased adoption of personalized medicine approaches using molecular glues for targeted therapies.
Global expansion into emerging markets will present new opportunities for market players, driven by growing healthcare infrastructure.
Strategic partnerships and mergers among key players will shape the competitive landscape and drive market consolidation.

CHAPTER NO. 1 : INTRODUCTION 20
1.1.1. Report Description 20
Purpose of the Report 20
USP & Key Offerings 20
1.1.2. Key Benefits for Stakeholders 20
1.1.3. Target Audience 21
1.1.4. Report Scope 21
CHAPTER NO. 2 : EXECUTIVE SUMMARY 22
2.1. Molecular Glues Market Snapshot 22
2.1.1. Global Molecular Glues Market, 2018 – 2032 (USD Million) 24
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 25
3.1. Russia-Ukraine and Israel-Palestine War Impacts 25
CHAPTER NO. 4 : MOLECULAR GLUES MARKET – INDUSTRY ANALYSIS 26
4.1. Introduction 26
4.2. Market Drivers 27
4.2.1. Driving Factor 1 Analysis 27
4.2.2. Driving Factor 2 Analysis 28
4.3. Market Restraints 29
4.3.1. Restraining Factor Analysis 29
4.4. Market Opportunities 30
4.4.1. Market Opportunity Analysis 30
4.5. Porter’s Five Forces Analysis 31
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 32
5.1. Company Market Share Analysis – 2023 32
5.1.1. Global Molecular Glues Market: Company Market Share, by Volume, 2023 32
5.1.2. Global Molecular Glues Market: Company Market Share, by Revenue, 2023 33
5.1.3. Global Molecular Glues Market: Top 6 Company Market Share, by Revenue, 2023 33
5.1.4. Global Molecular Glues Market: Top 3 Company Market Share, by Revenue, 2023 34
5.2. Global Molecular Glues Market Company Revenue Market Share, 2023 35
5.3. Company Assessment Metrics, 2023 36
5.3.1. Stars 36
5.3.2. Emerging Leaders 36
5.3.3. Pervasive Players 36
5.3.4. Participants 36
5.4. Start-ups /SMEs Assessment Metrics, 2023 36
5.4.1. Progressive Companies 36
5.4.2. Responsive Companies 36
5.4.3. Dynamic Companies 36
5.4.4. Starting Blocks 36
5.5. Strategic Developments 37
5.5.1. Acquisitions & Mergers 37
New Product Launch 37
Global Expansion 37
5.6. Key Players Product Matrix 38
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 39
6.1. PESTEL 39
6.1.1. Political Factors 39
6.1.2. Economic Factors 39
6.1.3. Social Factors 39
6.1.4. Technological Factors 39
6.1.5. Environmental Factors 39
6.1.6. Legal Factors 39
6.2. Adjacent Market Analysis 39
CHAPTER NO. 7 : MOLECULAR GLUES MARKET – BY TYPE SEGMENT ANALYSIS 40
7.1. Molecular Glues Market Overview, by Type Segment 40
7.1.1. Molecular Glues Market Revenue Share, By Type, 2023 & 2032 41
7.1.2. Molecular Glues Market Attractiveness Analysis, By Type 42
7.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 42
7.1.4. Molecular Glues Market Revenue, By Type, 2018, 2023, 2027 & 2032 43
7.2. Proteolysis Targeting Chimeras (PROTACs) 44
7.3. Specific & Non-genetic IAP-dependent Protein Erasers 45
7.4. Target Oriented Protein Degrader Optimizer 46
7.5. Lysosomal Targeting Chimeras 47
7.6. Others 48
CHAPTER NO. 8 : MOLECULAR GLUES MARKET – BY APPLICATION SEGMENT ANALYSIS 49
8.1. Molecular Glues Market Overview, by Application Segment 49
8.1.1. Molecular Glues Market Revenue Share, By Application, 2023 & 2032 50
8.1.2. Molecular Glues Market Attractiveness Analysis, By Application 51
8.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 51
8.1.4. Molecular Glues Market Revenue, By Application, 2018, 2023, 2027 & 2032 52
8.2. Therapeutics 53
8.2.1. Cancer Treatment 53
8.2.2. Neurodegenerative Diseases 54
8.2.3. Infectious Diseases 54
8.3. Diagnostic Tools 55
8.3.1. Biomarker Detection 55
8.3.2. Protein Interaction Mapping 56
8.4. Drug Development 57
8.5. Biological Research 58
8.6. Others 59
CHAPTER NO. 9 : MOLECULAR GLUES MARKET – BY PROCESS SEGMENT ANALYSIS 60
9.1. Molecular Glues Market Overview, by Process Segment 60
9.1.1. Molecular Glues Market Revenue Share, By Process, 2023 & 2032 61
9.1.2. Molecular Glues Market Attractiveness Analysis, By Process 62
9.1.3. Incremental Revenue Growth Opportunity, by Process, 2024 – 2032 62
9.1.4. Molecular Glues Market Revenue, By Process, 2018, 2023, 2027 & 2032 63
9.2. In Vitro Application 64
9.2.1. Direct Binding Assays 64
9.2.2. Competitive Binding Assays 65
9.3. In Vivo Application 66
9.3.1. Cellular Uptake Methods 66
9.3.2. Gene Delivery Systems 67
9.4. Ex Vivo Application 68
9.4.1. Tissue Culture 68
9.4.2. Organ Culture 69
CHAPTER NO. 10 : MOLECULAR GLUES MARKET – BY END USER SEGMENT ANALYSIS 70
10.1. Molecular Glues Market Overview, by End User Segment 70
10.1.1. Molecular Glues Market Revenue Share, By End User, 2023 & 2032 71
10.1.2. Molecular Glues Market Attractiveness Analysis, By End User 72
10.1.3. Incremental Revenue Growth Opportunity, by End User, 2024 – 2032 72
10.1.4. Molecular Glues Market Revenue, By End User, 2018, 2023, 2027 & 2032 73
10.2. Pharmaceutical Companies 74
10.2.1. Drug Discovery 74
10.2.2. Preclinical Research 75
10.2.3. Others 75
10.3. Biotechnology Companies 76
10.3.1. Research and Development 76
10.3.2. Product Development 77
10.3.3. Others 77
10.4. Diagnostic Laboratories 78
10.5. Academic and Research Institutions 79
10.6. Others 80
CHAPTER NO. 11 : MOLECULAR GLUES MARKET – GLOBAL ANALYSIS 81
11.1. Type 81
11.1.1. Global Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 81
11.1.2. Global Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 82
11.2. Application 83
11.2.1. Global Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 83
11.2.2. Global Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 83
11.3. Process 84
11.3.1. Global Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 84
11.3.2. Global Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 84
11.4. End User 85
11.4.1. Global Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 85
11.4.2. Global Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 85
CHAPTER NO. 12 : MOLECULAR GLUES MARKET – NORTH AMERICA 86
12.1. North America 86
12.1.1. Key Highlights 86
12.1.2. North America Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 87
12.1.3. North America Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 88
12.1.4. North America Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 90
12.1.5. North America Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 91
12.1.6. North America Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 92
12.2. U.S. 93
12.3. Canada 93
12.4. Mexico 93
CHAPTER NO. 13 : MOLECULAR GLUES MARKET – EUROPE 94
13.1. Europe 94
13.1.1. Key Highlights 94
13.1.2. Europe Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 95
13.1.3. Europe Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 96
13.1.4. Europe Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 98
13.1.5. Europe Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 99
13.1.6. Europe Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 100
13.2. UK 101
13.3. France 101
13.4. Germany 101
13.5. Italy 101
13.6. Spain 101
13.7. Russia 101
13.8. Belgium 101
13.9. Netherland 101
13.10. Austria 101
13.11. Sweden 101
13.12. Poland 101
13.13. Denmark 101
13.14. Switzerland 101
13.15. Rest of Europe 101
CHAPTER NO. 14 : MOLECULAR GLUES MARKET – ASIA PACIFIC 102
14.1. Asia Pacific 102
14.1.1. Key Highlights 102
14.1.2. Asia Pacific Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 103
14.1.3. Asia Pacific Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 104
14.1.4. Asia Pacific Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 106
14.1.5. Asia Pacific Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 107
14.1.6. Asia Pacific Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 108
14.2. China 109
14.3. Japan 109
14.4. South Korea 109
14.5. India 109
14.6. Australia 109
14.7. Thailand 109
14.8. Indonesia 109
14.9. Vietnam 109
14.10. Malaysia 109
14.11. Philippines 109
14.12. Taiwan 109
14.13. Rest of Asia Pacific 109
CHAPTER NO. 15 : MOLECULAR GLUES MARKET – LATIN AMERICA 110
15.1. Latin America 110
15.1.1. Key Highlights 110
15.1.2. Latin America Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 111
15.1.3. Latin America Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 112
15.1.4. Latin America Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 114
15.1.5. Latin America Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 115
15.1.6. Latin America Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 116
15.2. Brazil 117
15.3. Argentina 117
15.4. Peru 117
15.5. Chile 117
15.6. Colombia 117
15.7. Rest of Latin America 117
CHAPTER NO. 16 : MOLECULAR GLUES MARKET – MIDDLE EAST 118
16.1. Middle East 118
16.1.1. Key Highlights 118
16.1.2. Middle East Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 119
16.1.3. Middle East Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 120
16.1.4. Middle East Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 122
16.1.5. Middle East Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 123
16.1.6. Middle East Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 124
16.2. UAE 125
16.3. KSA 125
16.4. Israel 125
16.5. Turkey 125
16.6. Iran 125
16.7. Rest of Middle East 125
CHAPTER NO. 17 : MOLECULAR GLUES MARKET – AFRICA 126
17.1. Africa 126
17.1.1. Key Highlights 126
17.1.2. Africa Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 127
17.1.3. Africa Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 128
17.1.4. Africa Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 130
17.1.5. Africa Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 131
17.1.6. Africa Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 132
17.2. Egypt 133
17.3. Nigeria 133
17.4. Algeria 133
17.5. Morocco 133
17.6. Rest of Africa 133
CHAPTER NO. 18 : COMPANY PROFILES 134
18.1. Proxygen GmbH 134
18.1.1. Company Overview 134
18.1.2. Product Portfolio 134
18.1.3. Swot Analysis 134
18.1.4. Business Strategy 135
18.1.5. Financial Overview 135
18.2. Tocris Bioscience 136
18.3. Pfizer Inc. 136
18.4. Takeda Pharmaceuticals 136
18.5. LifeSensors Inc. 136
18.6. Evotec SE 136
18.7. Eli Lilly and Company 136
18.8. Bristol-Myers Squibb Company 136
18.9. C4 Therapeutics, Inc. 136
18.10. Seed Therapeutics, Inc. 136
18.11. Ranok Therapeutics Co. Ltd. 136
18.12. Venquis Therapeutics 136
18.13. Monte Rosa Therapeutics Inc. 136
18.14. Sygnature Discovery 136
18.15. Domainex 136
CHAPTER NO. 19 : RESEARCH METHODOLOGY 137
19.1. Research Methodology 137
19.1.1. Phase I – Secondary Research 138
19.1.2. Phase II – Data Modeling 138
Company Share Analysis Model 139
Revenue Based Modeling 139
19.1.3. Phase III – Primary Research 140
19.1.4. Research Limitations 141
Assumptions 141

List of Figures
FIG NO. 1. Global Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 24
FIG NO. 2. Porter’s Five Forces Analysis for Global Molecular Glues Market 31
FIG NO. 3. Company Share Analysis, 2023 32
FIG NO. 4. Company Share Analysis, 2023 33
FIG NO. 5. Company Share Analysis, 2023 33
FIG NO. 6. Company Share Analysis, 2023 34
FIG NO. 7. Molecular Glues Market – Company Revenue Market Share, 2023 35
FIG NO. 8. Molecular Glues Market Revenue Share, By Type, 2023 & 2032 41
FIG NO. 9. Market Attractiveness Analysis, By Type 42
FIG NO. 10. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 42
FIG NO. 11. Molecular Glues Market Revenue, By Type, 2018, 2023, 2027 & 2032 43
FIG NO. 12. Global Molecular Glues Market for Proteolysis Targeting Chimeras (PROTACs), Revenue (USD Million) 2018 – 2032 44
FIG NO. 13. Global Molecular Glues Market for Specific & Non-genetic IAP-dependent Protein Erasers, Revenue (USD Million) 2018 – 2032 45
FIG NO. 14. Global Molecular Glues Market for Target Oriented Protein Degrader Optimizer, Revenue (USD Million) 2018 – 2032 46
FIG NO. 15. Global Molecular Glues Market for Lysosomal Targeting Chimeras, Revenue (USD Million) 2018 – 2032 47
FIG NO. 16. Global Molecular Glues Market for Others, Revenue (USD Million) 2018 – 2032 48
FIG NO. 17. Molecular Glues Market Revenue Share, By Application, 2023 & 2032 50
FIG NO. 18. Market Attractiveness Analysis, By Application 51
FIG NO. 19. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 51
FIG NO. 20. Molecular Glues Market Revenue, By Application, 2018, 2023, 2027 & 2032 52
FIG NO. 21. Global Molecular Glues Market for Therapeutics, Revenue (USD Million) 2018 – 2032 53
FIG NO. 22. Global Molecular Glues Market for Cancer Treatment, Revenue (USD Million) 2018 – 2032 53
FIG NO. 23. Global Molecular Glues Market forNeurodegenerative Diseases, Revenue (USD Million) 2018 – 2032 54
FIG NO. 24. Global Molecular Glues Market for Infectious Diseases, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Global Molecular Glues Market for Diagnostic Tools, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Global Molecular Glues Market for Biomarker Detection, Revenue (USD Million) 2018 – 2032 55
FIG NO. 27. Global Molecular Glues Market forProtein Interaction Mapping, Revenue (USD Million) 2018 – 2032 56
FIG NO. 28. Global Molecular Glues Market for Drug Development, Revenue (USD Million) 2018 – 2032 57
FIG NO. 29. Global Molecular Glues Market for Biological Research, Revenue (USD Million) 2018 – 2032 58
FIG NO. 30. Global Molecular Glues Market for Others, Revenue (USD Million) 2018 – 2032 59
FIG NO. 31. Molecular Glues Market Revenue Share, By Process, 2023 & 2032 61
FIG NO. 32. Market Attractiveness Analysis, By Process 62
FIG NO. 33. Incremental Revenue Growth Opportunity by Process, 2024 – 2032 62
FIG NO. 34. Molecular Glues Market Revenue, By Process, 2018, 2023, 2027 & 2032 63
FIG NO. 35. Global Molecular Glues Market for In Vitro Application, Revenue (USD Million) 2018 – 2032 64
FIG NO. 36. Global Molecular Glues Market for Direct Binding Assays, Revenue (USD Million) 2018 – 2032 64
FIG NO. 37. Global Molecular Glues Market forCompetitive Binding Assays, Revenue (USD Million) 2018 – 2032 65
FIG NO. 38. Global Molecular Glues Market for In Vivo Application, Revenue (USD Million) 2018 – 2032 66
FIG NO. 39. Global Molecular Glues Market forCellular Uptake Methods, Revenue (USD Million) 2018 – 2032 66
FIG NO. 40. Global Molecular Glues Market forGene Delivery Systems, Revenue (USD Million) 2018 – 2032 67
FIG NO. 41. Global Molecular Glues Market for Ex Vivo Application, Revenue (USD Million) 2018 – 2032 68
FIG NO. 42. Global Molecular Glues Market for Tissue Culture, Revenue (USD Million) 2018 – 2032 68
FIG NO. 43. Global Molecular Glues Market for Organ Culture, Revenue (USD Million) 2018 – 2032 69
FIG NO. 44. Molecular Glues Market Revenue Share, By End User, 2023 & 2032 71
FIG NO. 45. Market Attractiveness Analysis, By End User 72
FIG NO. 46. Incremental Revenue Growth Opportunity by End User, 2024 – 2032 72
FIG NO. 47. Molecular Glues Market Revenue, By End User, 2018, 2023, 2027 & 2032 73
FIG NO. 48. Global Molecular Glues Market for Pharmaceutical Companies, Revenue (USD Million) 2018 – 2032 74
FIG NO. 49. Global Molecular Glues Market forDrug Discovery, Revenue (USD Million) 2018 – 2032 74
FIG NO. 50. Global Molecular Glues Market forPreclinical Research, Revenue (USD Million) 2018 – 2032 75
FIG NO. 51. Global Molecular Glues Market for Others, Revenue (USD Million) 2018 – 2032 75
FIG NO. 52. Global Molecular Glues Market for Biotechnology Companies, Revenue (USD Million) 2018 – 2032 76
FIG NO. 53. Global Molecular Glues Market forResearch and Development, Revenue (USD Million) 2018 – 2032 76
FIG NO. 54. Global Molecular Glues Market forProduct Development, Revenue (USD Million) 2018 – 2032 77
FIG NO. 55. Global Molecular Glues Market for Others, Revenue (USD Million) 2018 – 2032 77
FIG NO. 56. Global Molecular Glues Market for Diagnostic Laboratories, Revenue (USD Million) 2018 – 2032 78
FIG NO. 57. Global Molecular Glues Market for Academic and Research Institutions, Revenue (USD Million) 2018 – 2032 79
FIG NO. 58. Global Molecular Glues Market for Others, Revenue (USD Million) 2018 – 2032 80
FIG NO. 59. North America Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 86
FIG NO. 60. Europe Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 94
FIG NO. 61. Asia Pacific Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 102
FIG NO. 62. Latin America Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 110
FIG NO. 63. Middle East Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 118
FIG NO. 64. Africa Molecular Glues Market Revenue, 2018 – 2032 (USD Million) 126
FIG NO. 65. Research Methodology – Detailed View 137
FIG NO. 66. Research Methodology 138

List of Tables
TABLE NO. 1. : Global Molecular Glues Market: Snapshot 22
TABLE NO. 2. : Drivers for the Molecular Glues Market: Impact Analysis 27
TABLE NO. 3. : Restraints for the Molecular Glues Market: Impact Analysis 29
TABLE NO. 4. : Global Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 81
TABLE NO. 5. : Global Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 82
TABLE NO. 6. : Global Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 83
TABLE NO. 7. : Global Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 83
TABLE NO. 8. : Global Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 84
TABLE NO. 9. : Global Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 84
TABLE NO. 10. : Global Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 85
TABLE NO. 11. : Global Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 85
TABLE NO. 12. : North America Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 87
TABLE NO. 13. : North America Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 87
TABLE NO. 14. : North America Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 88
TABLE NO. 15. : North America Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 88
TABLE NO. 16. : North America Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 90
TABLE NO. 17. : North America Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 90
TABLE NO. 18. : North America Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 91
TABLE NO. 19. : North America Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 91
TABLE NO. 20. : North America Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 92
TABLE NO. 21. : North America Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 92
TABLE NO. 22. : Europe Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 95
TABLE NO. 23. : Europe Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 95
TABLE NO. 24. : Europe Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 96
TABLE NO. 25. : Europe Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 96
TABLE NO. 26. : Europe Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 98
TABLE NO. 27. : Europe Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 98
TABLE NO. 28. : Europe Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 99
TABLE NO. 29. : Europe Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 99
TABLE NO. 30. : Europe Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 100
TABLE NO. 31. : Europe Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 100
TABLE NO. 32. : Asia Pacific Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 103
TABLE NO. 33. : Asia Pacific Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 103
TABLE NO. 34. : Asia Pacific Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 104
TABLE NO. 35. : Asia Pacific Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 104
TABLE NO. 36. : Asia Pacific Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 106
TABLE NO. 37. : Asia Pacific Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 106
TABLE NO. 38. : Asia Pacific Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 107
TABLE NO. 39. : Asia Pacific Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 107
TABLE NO. 40. : Asia Pacific Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 108
TABLE NO. 41. : Asia Pacific Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 108
TABLE NO. 42. : Latin America Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 111
TABLE NO. 43. : Latin America Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 111
TABLE NO. 44. : Latin America Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 112
TABLE NO. 45. : Latin America Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 112
TABLE NO. 46. : Latin America Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 114
TABLE NO. 47. : Latin America Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 114
TABLE NO. 48. : Latin America Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 115
TABLE NO. 49. : Latin America Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 115
TABLE NO. 50. : Latin America Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 116
TABLE NO. 51. : Latin America Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 116
TABLE NO. 52. : Middle East Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 119
TABLE NO. 53. : Middle East Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 119
TABLE NO. 54. : Middle East Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 120
TABLE NO. 55. : Middle East Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 120
TABLE NO. 56. : Middle East Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 122
TABLE NO. 57. : Middle East Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 122
TABLE NO. 58. : Middle East Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 123
TABLE NO. 59. : Middle East Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 123
TABLE NO. 60. : Middle East Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 124
TABLE NO. 61. : Middle East Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 124
TABLE NO. 62. : Africa Molecular Glues Market Revenue, By Country, 2018 – 2023 (USD Million) 127
TABLE NO. 63. : Africa Molecular Glues Market Revenue, By Country, 2024 – 2032 (USD Million) 127
TABLE NO. 64. : Africa Molecular Glues Market Revenue, By Type, 2018 – 2023 (USD Million) 128
TABLE NO. 65. : Africa Molecular Glues Market Revenue, By Type, 2024 – 2032 (USD Million) 128
TABLE NO. 66. : Africa Molecular Glues Market Revenue, By Application, 2018 – 2023 (USD Million) 130
TABLE NO. 67. : Africa Molecular Glues Market Revenue, By Application, 2024 – 2032 (USD Million) 130
TABLE NO. 68. : Africa Molecular Glues Market Revenue, By Process, 2018 – 2023 (USD Million) 131
TABLE NO. 69. : Africa Molecular Glues Market Revenue, By Process, 2024 – 2032 (USD Million) 131
TABLE NO. 70. : Africa Molecular Glues Market Revenue, By End User, 2018 – 2023 (USD Million) 132
TABLE NO. 71. : Africa Molecular Glues Market Revenue, By End User, 2024 – 2032 (USD Million) 132

Frequently Asked Questions

What is the current size of the Global Molecular Glues Market?

The Global Molecular Glues Market is projected to grow from USD 58,021.34 million in 2023 to USD 95,557.03 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.70%.

What factors are driving the growth of the Global Molecular Glues Market?

The market is driven by increasing demand for innovative therapeutic approaches to treat complex diseases, advancements in drug discovery technologies, and the rising focus on targeted protein degradation, especially in oncology and neurodegenerative disorders.

What are the key segments within the Global Molecular Glues Market?

Key segments include Types such as Proteolysis Targeting Chimeras (PROTACs) and Lysosomal Targeting Chimeras, Applications like Therapeutics (including Cancer Treatment and Neurodegenerative Diseases), Diagnostic Tools, Drug Development, and Biological Research.

What are some challenges faced by the Global Molecular Glues Market?

Challenges include high development costs, technical difficulties in designing effective molecular glues, safety and toxicity concerns, intellectual property complexities, and navigating regulatory hurdles.

Who are the major players in the Global Molecular Glues Market?

Major players include Pfizer Inc., Bristol-Myers Squibb, Eli Lilly and Company, Takeda Pharmaceuticals, Proxygen GmbH, and C4 Therapeutics, among others.

Purchase Options

Single User

$3699

Multi User

$4699

Enterprise

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –